Stock Price Movement and Market Context
On 21 Jan 2026, Poly Medicure Ltd’s share price touched an intraday low of Rs.1555, marking its lowest level in the past year. This decline came alongside a day’s fall of 3.47%, with the stock trading below all key moving averages – including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock has been on a downward trajectory for two consecutive sessions, losing 5.44% over this period.
The broader healthcare services sector, particularly the Medical Equipment, Supplies, and Accessories segment, also experienced a decline of 3.75% on the same day. The Sensex opened 385.82 points lower and was trading at 81,672.68, down 0.62%, continuing its three-week losing streak with a cumulative fall of 4.77%. The Sensex itself is positioned below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating some longer-term support.
Performance Over the Past Year
Poly Medicure Ltd’s stock has underperformed significantly over the last twelve months, delivering a negative return of 37.51%, in stark contrast to the Sensex’s positive 7.82% gain and the BSE500’s 6.04% rise. The stock’s 52-week high was Rs.2936.7, underscoring the extent of the recent correction.
Despite the stock’s price decline, the company’s profits have increased by 22.8% over the past year, suggesting that the market’s valuation has not kept pace with earnings growth. The company’s PEG ratio stands at 2, indicating a valuation that factors in growth but may be considered elevated relative to earnings expansion.
Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!
- - Long-term growth stock
- - Multi-quarter performance
- - Sustainable gains ahead
Financial Metrics and Valuation
Poly Medicure Ltd’s return on equity (ROE) is recorded at 12.4%, while the stock trades at a price-to-book value of 5.7, indicating a relatively expensive valuation compared to its book value. The company’s dividend payout ratio (DPR) is notably low at 10.70%, which may reflect a conservative dividend policy or reinvestment strategy.
The debtors turnover ratio for the half-year period stands at 4.02 times, one of the lowest in recent periods, signalling slower collection cycles. However, the company maintains a low average debt-to-equity ratio of zero, reflecting a debt-free capital structure that reduces financial risk.
Sector Position and Institutional Holdings
With a market capitalisation of Rs.16,556 crores, Poly Medicure Ltd is the second largest company in the healthcare services sector, accounting for 15.87% of the sector’s total market cap, behind Lenskart Solutions. Its annual sales of Rs.1,712.13 crores represent 15.86% of the industry’s revenue, underscoring its significant presence.
Institutional investors hold a substantial 23.31% stake in the company, indicating confidence from entities with extensive analytical resources. This level of institutional ownership often reflects a thorough assessment of the company’s fundamentals and prospects.
Sector and Market Influences
The healthcare services sector has faced headwinds in recent sessions, with the Medical Equipment/Supplies/Accessories segment declining by 3.75% on the day Poly Medicure hit its 52-week low. The broader market environment has also been challenging, with the Sensex experiencing a three-week consecutive decline and trading below its 50-day moving average.
These factors have contributed to the downward pressure on Poly Medicure’s stock price, which has lagged behind both sectoral and market benchmarks over the past year.
Considering Poly Medicure Ltd? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Mojo Score and Rating Update
Poly Medicure Ltd currently holds a Mojo Score of 37.0 and a Mojo Grade of Sell, reflecting a downgrade from its previous Hold rating as of 28 May 2025. The market cap grade is 3, indicating a mid-tier valuation relative to market capitalisation standards.
The downgrade aligns with the stock’s recent price performance and valuation metrics, as well as its relative underperformance compared to sector and market indices.
Summary of Key Price and Performance Indicators
The stock’s 52-week low of Rs.1555 represents a significant decline from its 52-week high of Rs.2936.7. Over the last two trading days, the stock has fallen by 5.44%, with an intraday low of Rs.1555 marking the new bottom. The sector’s decline of 3.75% and the Sensex’s 0.62% fall on the same day provide a broader context for the stock’s movement.
Poly Medicure’s trading below all major moving averages further emphasises the current downward momentum in the share price.
Conclusion
Poly Medicure Ltd’s fall to a 52-week low of Rs.1555 on 21 Jan 2026 reflects a combination of sectoral softness, broader market weakness, and valuation considerations. Despite profit growth over the past year, the stock has experienced significant price correction and a downgrade in its Mojo rating. The company’s strong market position and low debt levels remain notable features amid the current valuation and price pressures.
Unlock special upgrade rates for a limited period. Start Saving Now →
